| Home | E-Submission | Sitemap | Editorial Office |  
REVIEW ARTICLE 2020 August 27
Epigenetic Approaches to the Treatment of Renal Cell Cancer
To summarize the epigenetics in renal cell carcinoma (RCC) and discuss the potential use of epigenetic modifiers as RCC biomarkers and treatments. Pertinent articles available on PubMed and google scholar database pertaining to kidney cancer and epigenetics were reviewed. Metast...
REVIEW ARTICLE 2020 August 27
Approaches for Personalized Drug Development in Bladder Cancer Patients
Bladder cancer, which affects the bladder mucosa, is the ninth most common disease worldwide. There are many types of cancerous tissue in the bladder. Most exhibit low malignancy, but their recurrence rate is higher in comparison to more malignant tissues. Only 10%–15% progress...
Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer
Purpose: To determine an appropriate surgical technique, it is important to predict pathological results for patients with clinically localized prostate cancer (PCa) eligible for nerve-sparing radical prostatectomy (NSRP). Several studies have highlighted that serum testosterone...
Current Issue
Volume 18(2); August 2020
Volume 18(1); April 2020
Volume 17(3); December 2019
Volume 17(2); August 2019
Volume 17(1); April 2019
RSS feed
Review Articles
73 Bacillus Calmette-Guérin 부족 시 고위험 비근침윤성방광암의 치료 대안
유정완, 김연주, 태범식, 박재영
Korean J Urol Oncol. 2020;18(2):73-77.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.73
78 Epigenetic Approaches to the Treatment of Renal Cell Cancer
Seong Hwi Hong, Jiyoung Lee, Eun Bi Jang, Sung Yul Park, Hong-Sang Moon, Young Eun Yoon
Korean J Urol Oncol. 2020;18(2):78-90.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.78
91 방광암 환자의 개인 맞춤형 약물 개발의 접근법 제시
설향숙, 장인호
Korean J Urol Oncol. 2020;18(2):91-98.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.91
99 New Androgen Receptor Axis-Targeted Agents in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer: From Bench to Clinical Trials
Jeong Hee Hong
Korean J Urol Oncol. 2020;18(2):99-108.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.99
Original Articles
109 Risk Factors for pT3a Prostate Cancer in the Patients With cT1-2 on Preoperative Multiparametric Magnetic Resonance Imaging
Kyung Hwan Kim, Ja Yoon Ku, Won Young Park, Seung Baek Hong, Suk Kim, Hong Koo Ha
Korean J Urol Oncol. 2020;18(2):109-115.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.109
116 Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer
Soon Oh Kwon, Kyeong-Hyeon Byeon, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Ghil Suk Yoon, Jun Nyung Lee, Tae Gyun Kwon
Korean J Urol Oncol. 2020;18(2):116-123.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.116
124 진행성 전립선암의 치료: 국내 전립선암 전문가로 구성된 Prostate Cancer Summit (PCAS) 2016을 통한 전립선암 치료 지침의 확인
장춘태, 김형준, 김명기, 박성우, 박승철, 박재영, 이동현, 이승환, 전황균, 정재훈, 정 현, 조문기, 홍성후, 곽 철, 이지열, 권동득, 김청수, 전성수
Korean J Urol Oncol. 2020;18(2):124-139.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.124
140 세포독성 항암화학요법을 받을 수 없는 환자에서의 Estramustine Phosphate 단독요법
류재현, 김상진, 김윤범, 정태영, 문경태, 조정만, 유탁근
Korean J Urol Oncol. 2020;18(2):140-146.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.140
147 한국인에서 전립선암을 예측하는 데 있어 Prostate Health Index Density의 임상적 유용성에 관한 전향적, 다기관 연구
송기현, 박홍주, 이상욱, 강태욱, 정재흥, 정현철, 김성진, 박종연, 김정현
Korean J Urol Oncol. 2020;18(2):147-154.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.147
Case Report
155 Open Partial Nephrectomy With Zero Ischemia Technique Using Thulium Laser: Our Experience of 4 Cases
Kumar Prem, Pankaj Kumar, Zia Ur Rehman, Somesh Janoria
Korean J Urol Oncol. 2020;18(2):155-160.   Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.155
Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society. All rights reserved.                 developed in m2community
Close layer
prev next